Adherence to post-therapeutic multidisciplinary tumor board recommendation and its influence on oncological outcomes in high-risk prostate cancer patients following radical prostatectomy.
가이드라인
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
802 patients, 408 (51.
I · Intervention 중재 / 시술
aRT, whereas 287 (70%) were non-adherent to aRT-MDT recommendation
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] Solely a fraction of patients followed the recommendation to undergo aRT. Patients adherent to aRT recommendation demonstrated lower rates of subsequent PCa recurrences, albeit not (yet) translating into CSS/OS differences.
[BACKGROUND] In prostate cancer (PCa) patients treated with radical prostatectomy (RP), multidisciplinary tumor boards (MDT) issue recommendations to undergo adjuvant (aRT) or salvage radiotherapy (sR
- p-value p < 0.001
- 추적기간 3 years
APA
Hoeh B, Kwe J, et al. (2026). Adherence to post-therapeutic multidisciplinary tumor board recommendation and its influence on oncological outcomes in high-risk prostate cancer patients following radical prostatectomy.. International urology and nephrology, 58(2), 433-440. https://doi.org/10.1007/s11255-025-04620-0
MLA
Hoeh B, et al.. "Adherence to post-therapeutic multidisciplinary tumor board recommendation and its influence on oncological outcomes in high-risk prostate cancer patients following radical prostatectomy.." International urology and nephrology, vol. 58, no. 2, 2026, pp. 433-440.
PMID
40646389 ↗
Abstract 한글 요약
[BACKGROUND] In prostate cancer (PCa) patients treated with radical prostatectomy (RP), multidisciplinary tumor boards (MDT) issue recommendations to undergo adjuvant (aRT) or salvage radiotherapy (sRT). However, reliable data regarding the adherence rate to MDT recommendations and subsequently its impact on oncological outcomes are scarce.
[METHODS] We retrospectively identified patients treated with RP within a certified prostate cancer center between 2012 and 2016, receiving an MDT recommendation to undergo adjuvant or salvage radiotherapy following RP due to adverse pathological features (non-organ confined disease, positive surgical margin, positive lymph node). Patients with a follow-up < 3 years were excluded. Among patients recommended to undergo aRT, adherence rate was calculated. Patients adherent vs. non-adherent to aRT recommendation were compared regarding biochemical recurrence (BCR), PSA failure following aRT or sRT, and cancer-specific (CSS) and overall survival (OS).
[RESULTS] Of 802 patients, 408 (51.5%) were recommended to undergo aRT. Among those, 121 (30%) received aRT, whereas 287 (70%) were non-adherent to aRT-MDT recommendation. In multivariable logistic regression models, age, performance status and presence of adverse pathological features represented statistically significant predictors to undergo aRT. Rates of BCR (40.4 vs. 66.6%) as well as subsequent median time of PSA failure following radiotherapy (83 vs. 42 months) favored patients adherent to aRT recommendations (both p < 0.001). No differences were recorded in CSS and OS analyses regarding adherence to aRT recommendations.
[CONCLUSION] Solely a fraction of patients followed the recommendation to undergo aRT. Patients adherent to aRT recommendation demonstrated lower rates of subsequent PCa recurrences, albeit not (yet) translating into CSS/OS differences.
[METHODS] We retrospectively identified patients treated with RP within a certified prostate cancer center between 2012 and 2016, receiving an MDT recommendation to undergo adjuvant or salvage radiotherapy following RP due to adverse pathological features (non-organ confined disease, positive surgical margin, positive lymph node). Patients with a follow-up < 3 years were excluded. Among patients recommended to undergo aRT, adherence rate was calculated. Patients adherent vs. non-adherent to aRT recommendation were compared regarding biochemical recurrence (BCR), PSA failure following aRT or sRT, and cancer-specific (CSS) and overall survival (OS).
[RESULTS] Of 802 patients, 408 (51.5%) were recommended to undergo aRT. Among those, 121 (30%) received aRT, whereas 287 (70%) were non-adherent to aRT-MDT recommendation. In multivariable logistic regression models, age, performance status and presence of adverse pathological features represented statistically significant predictors to undergo aRT. Rates of BCR (40.4 vs. 66.6%) as well as subsequent median time of PSA failure following radiotherapy (83 vs. 42 months) favored patients adherent to aRT recommendations (both p < 0.001). No differences were recorded in CSS and OS analyses regarding adherence to aRT recommendations.
[CONCLUSION] Solely a fraction of patients followed the recommendation to undergo aRT. Patients adherent to aRT recommendation demonstrated lower rates of subsequent PCa recurrences, albeit not (yet) translating into CSS/OS differences.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.